Osteoarthritis research findings show Fortigel to promote the regeneration of cartilage tissue

Results of two independent investigations have shown that the natural substance Fortigel stimulates the regeneration of cartilage.

They were recently presented at the congress of the Osteoarthritis Research Society International (OARSI) in Montreal, Canada. A clinical trial performed by Harvard Medical School and Tufts Medical Center has also demonstrated the efficacy of Fortigel on the basis of magnetic resonance images (MRIs). Working with Kiel University, scientists at the Kiel-based Collagen Research Institute (CRI) then gathered experimental evidence of the effects of Fortigel on cartilage cells.

Fortigel is developed by Gelita AG to prevent and treat joint disorders and osteoarthritis. The administration of Fortigel can prevent joint degeneration and counteract load-induced wear of the articular cartilage. “Unlike other substances which focus on short-term pain relief, the substance tackles the root causes of osteoarthritis and cartilage degeneration,” says Dr Klaus Flechsenhar, director of Medical Research at Gelita AG. Previous clinical trials have also showed shown that the substance promotes mobility and reduces pain.